D

DaVita Clinical Research | Houston, TX

Research site

(Unclaimed)

Location

2010 Naomi Street, Suite B, Houston, Texas, United States of America

Site insights

Top conditions

Top treatments

Bardoxolone Methyl

AP306

Clazakizumab

Selonsertib

SNF472

Pilocarpine

BI 685509

Parent organization

This site is a part of DaVita Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 8 total trials

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

This study is being conducted to characterize the safety, tolerability, and efficacy of AP306 at fixed doses in adults with hyperphosphatemia receivi...

Not yet enrolling

End Stage Renal Disease on Dialysis

Chronic Kidney Disease Requiring Chronic Dialysis

Drug: AP306 75 mg TID

Drug: AP306 150 mg BID

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a do...

Enrolling

Atherosclerotic Cardiovascular Disease

Atherosclerotic Cardiovascular Disease in Patients With ESKD

Drug: Placebo

Drug: CSL300